Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Role of Cyclic Adenosine 3':5'-Monophosphate in the Regulation of Tyrosine 3-monooxygenase Activity

MARTIN CHALFIE, LAUREL SETTIPANI and ROBERT L. PERLMAN
Molecular Pharmacology March 1979, 15 (2) 263-270;
MARTIN CHALFIE
Department of Physiology, Harvard Medical School, 25 Shattuck Street, Boston, Mass. 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAUREL SETTIPANI
Department of Physiology, Harvard Medical School, 25 Shattuck Street, Boston, Mass. 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT L. PERLMAN
Department of Physiology, Harvard Medical School, 25 Shattuck Street, Boston, Mass. 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The activity of tyrosine 3-monooxygenase (TH) was measured in extracts of cell suspensions prepared from a rat pheochromocytoma. Incubation of the cells with cholera toxin (0.1-1 µg/ml) or dibutyryl cAMP (1 mM) leads to an increase in TH activity in the cells. The effects of these agents are not dependent upon the presence of extracellular Ca2+, and are not blocked by diphenylhydantoin, an inhibitor of Ca2+ uptake into the cells. The activation of TH by cholera toxin occurs after a lag period of 10-15 min, and is associated with a large rise in cAMP levels in the cells. Cholera toxin and dibutyryl cAMP increase the rate of catecholamine biosynthesis in these cells, but have no effect on the secretion of catecholamine from the cells. Incubation of the cells in media containing 56 mM K+ also leads to the activation of TH. However, this treatment does not result in a rise in cAMP levels, nor does it increase the rate of formation of [3H]cAMP from [3H]adenine in these cells. These results are consistent with the hypothesis that TH can be regulated by two distinct pathways, one of which involves cAMP, and the other of which is independent of the nucleotide.

ACKNOWLEDGMENTS We are grateful to Dr. Shields Warren and Ms. Rosanna Chute for supplying the pheochromocytoma used in these studies. We thank Dr. William Moyle for his help with the cAMP assays.

  • Copyright © 1979 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 15, Issue 2
1 Mar 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Cyclic Adenosine 3':5'-Monophosphate in the Regulation of Tyrosine 3-monooxygenase Activity
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Role of Cyclic Adenosine 3':5'-Monophosphate in the Regulation of Tyrosine 3-monooxygenase Activity

MARTIN CHALFIE, LAUREL SETTIPANI and ROBERT L. PERLMAN
Molecular Pharmacology March 1, 1979, 15 (2) 263-270;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Role of Cyclic Adenosine 3':5'-Monophosphate in the Regulation of Tyrosine 3-monooxygenase Activity

MARTIN CHALFIE, LAUREL SETTIPANI and ROBERT L. PERLMAN
Molecular Pharmacology March 1, 1979, 15 (2) 263-270;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics